LISA NAZARENUS: Open Payments
NPI 1225200306 · PORTLAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,613 in 93 payments from 21 companies in 2025. Trend: 2023 $1,781 · 2024 $1,840 · 2025 $1,613
Food & beverage: $1,613
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $243 |
| Novo Nordisk Inc | 11 | $239 |
| PFIZER INC. | 9 | $208 |
| ABBVIE INC. | 19 | $206 |
| Lilly USA, LLC | 15 | $169 |
| Axsome Therapeutics, Inc. | 4 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
Products named: XIFAXAN, NURTEC ODT, Ozempic, UBRELVY, Auvelity, CAPLYTA, QULIPTA, JARDIANCE.
Industry payments across TN — which companies pay providers there.
